Retour

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update

Stocks Earnings Releases and Operating Results

– Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast cancer, including the VERITAC-2 Phase 3 trial in the second-line setting and the study lead-in for the VERITAC-3 Phase 3 trial in the first-line setting –

GlobeNewswire Inc. • 07/05/2024 à 13:00:00
Arvinas, Inc
Address: 395 WINCHESTER AVE
Postal Code: 06511
City: NEW HAVEN
State: CT
Phone Number: 203-535-1456
Website: https://www.arvinas.com
Status: Active
Company Info

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

List Date2018-09-27
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001655759
Composite figiBBG00LW7YK82
Share Class figiBBG00LW7YL08
Market Cap2,236,354,198 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees445
Share Class Shares Outstanding68430000
Weighted Shares Outstanding68431891
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
32.2
32.565
32.3
32.259
31.2
Variance
-1.12%
0.82%
3%
3.39%
-0.39%
Open
32.565
32.3
31.36
31.2
31.321
Highest
33.09
36.524
33.895
32.526
32.379
Lowest
33.065
36.51
33.805
32.485
32.375
History
PeriodVarhighestlowest
1 week
2.81%
32.379
32.375
1 month
-7.09%
35.759
32.252
3 month
-40.71%
54.31
32.252
6 month
44.78%
22.38
20.28
1 year
41.73%
23.11
13.57
3 year
-51.04%
65.77
13.57
5 year
45.9%
22.49
13.57
10 year
53.33%
21.25
10.19
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-08 2023-11-07 UNPUB
Assets 1,175,800,000 1,083,500,000 1,058,300,000 UNPUB
Current Assets 1,148,200,000 1,056,700,000 1,033,000,000 UNPUB
Current Liabilities 282,900,000 306,900,000 317,300,000 UNPUB
Equity 511,000,000 463,600,000 457,200,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 511,000,000 463,600,000 457,200,000 UNPUB
Liabilities 664,800,000 619,900,000 601,100,000 UNPUB
Liabilities And Equity 1,175,800,000 1,083,500,000 1,058,300,000 UNPUB
Noncurrent Assets 27,600,000 26,800,000 25,300,000 UNPUB
Noncurrent Liabilities 381,900,000 313,000,000 283,800,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-08 2023-11-07 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 48,900,000 -39,600,000 23,100,000 UNPUB
Net Cash Flow, Continuing 48,900,000 -39,600,000 23,100,000 UNPUB
Net Cash Flow From Financing Activities 1,500,000 500,000 37,900,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 1,500,000 500,000 37,900,000 UNPUB
Net Cash Flow From Investing Activities 138,600,000 48,600,000 70,000,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 138,600,000 48,600,000 70,000,000 UNPUB
Net Cash Flow From Operating Activities -91,200,000 -88,700,000 -84,800,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -91,200,000 -88,700,000 -84,800,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-08 2023-11-07 UNPUB
Comprehensive Income/Loss -75,300,000 -66,200,000 -61,000,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -75,300,000 -66,200,000 -61,000,000 UNPUB
Other Comprehensive Income/Loss -75,300,000 -66,200,000 -61,000,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-05 2023-08-08 2023-11-07 UNPUB
Basic Earnings Per Share -2 -1 -1 UNPUB
Benefits Costs and Expenses 113,700,000 120,100,000 98,500,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 113,700,000 120,100,000 98,500,000 UNPUB
Diluted Earnings Per Share -2 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -80,800,000 -65,300,000 -63,900,000 UNPUB
Income/Loss From Continuing Operations Before Tax -81,200,000 -65,600,000 -63,900,000 UNPUB
Income Tax Expense/Benefit -400,000 -300,000 0 UNPUB
Interest Expense, Operating 0 0 0 UNPUB
Net Income/Loss -81,900,000 -66,600,000 -64,000,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -81,900,000 -66,600,000 -64,000,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -81,900,000 -66,600,000 -64,000,000 UNPUB
Operating Expenses 120,200,000 129,100,000 108,500,000 UNPUB
Operating Income/Loss -87,700,000 -74,600,000 -73,900,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 32,500,000 54,500,000 34,600,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-05 2022-08-04 2022-11-09 2023-02-23
Assets 1,488,300,000 1,407,000,000 1,334,800,000 1,268,800,000
Current Assets 1,457,000,000 1,376,400,000 1,304,700,000 1,240,200,000
Current Liabilities 238,000,000 238,200,000 244,600,000 295,100,000
Equity 723,300,000 670,600,000 621,500,000 564,900,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 723,300,000 670,600,000 621,500,000 564,900,000
Liabilities 765,000,000 736,400,000 713,300,000 703,900,000
Liabilities And Equity 1,488,300,000 1,407,000,000 1,334,800,000 1,268,800,000
Noncurrent Assets 31,300,000 30,600,000 30,100,000 28,600,000
Noncurrent Liabilities 0 0 468,700,000 408,800,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-05 2022-08-04 2022-11-09 2023-02-23
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -46,000,000 30,900,000 40,400,000 -26,000,000
Net Cash Flow, Continuing -46,000,000 30,900,000 40,400,000 -26,000,000
Net Cash Flow From Financing Activities 2,500,000 500,000 1,200,000 4,700,000
Net Cash Flow From Financing Activities, Continuing 2,500,000 500,000 1,200,000 4,700,000
Net Cash Flow From Investing Activities 8,600,000 109,000,000 105,800,000 242,800,000
Net Cash Flow From Investing Activities, Continuing 8,600,000 109,000,000 105,800,000 242,800,000
Net Cash Flow From Operating Activities -57,100,000 -78,600,000 -66,600,000 -273,500,000
Net Cash Flow From Operating Activities, Continuing -57,100,000 -78,600,000 -66,600,000 -273,500,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-05 2022-08-04 2022-11-09 2023-02-23
Comprehensive Income/Loss -77,500,000 -73,300,000 -69,000,000 -297,000,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -77,500,000 -73,300,000 -69,000,000 -297,000,000
Other Comprehensive Income/Loss -14,100,000 -73,300,000 -69,000,000 -297,000,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-05 2022-08-04 2022-11-09 2023-02-23
Basic Earnings Per Share -1 -1 -1 -5
Benefits Costs and Expenses 0 0 0 382,400,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 84,200,000 99,600,000 97,500,000 382,400,000
Diluted Earnings Per Share -1 -1 -1 -5
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -63,400,000 -70,000,000 -66,200,000 -271,900,000
Income/Loss From Continuing Operations Before Tax 24,200,000 31,300,000 30,300,000 -251,000,000
Income Tax Expense/Benefit 4,500,000 3,400,000 2,200,000 20,900,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -63,400,000 -70,000,000 -66,200,000 -282,500,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -63,400,000 -70,000,000 -66,200,000 -282,500,000
Net Income/Loss Available To Common Stockholders, Basic -63,400,000 -70,000,000 -66,200,000 -282,500,000
Operating Expenses 84,200,000 99,600,000 97,500,000 394,600,000
Operating Income/Loss -60,000,000 -68,300,000 -67,200,000 -263,200,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 24,200,000 31,300,000 30,300,000 131,400,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-05 2021-11-03 2022-02-28
Assets 681,772,443 644,026,885 1,604,865,210 1,581,600,000
Current Assets 664,656,758 627,733,962 1,576,150,721 1,552,500,000
Current Liabilities 40,371,914 41,820,346 182,507,756 261,700,000
Equity 615,298,020 582,947,174 817,737,157 781,700,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 615,298,020 582,947,174 817,737,157 781,700,000
Liabilities 66,474,423 61,079,711 787,128,053 799,900,000
Liabilities And Equity 681,772,443 644,026,885 1,604,865,210 1,581,600,000
Noncurrent Assets 17,115,685 16,292,923 28,714,489 29,100,000
Noncurrent Liabilities 0 0 604,620,297 538,200,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-05 2021-11-03 2022-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -242,304,826 -292,841,963 206,936,392 -475,600,000
Net Cash Flow, Continuing -242,304,826 -292,841,963 206,936,392 -475,600,000
Net Cash Flow From Financing Activities 4,480,692 3,613,289 266,507,208 278,600,000
Net Cash Flow From Financing Activities, Continuing 4,480,692 3,613,289 266,507,208 278,600,000
Net Cash Flow From Investing Activities -207,817,053 -249,052,071 -741,097,364 -1,313,600,000
Net Cash Flow From Investing Activities, Continuing -207,817,053 -249,052,071 -741,097,364 -1,313,600,000
Net Cash Flow From Operating Activities -38,968,465 -47,403,181 681,526,548 559,400,000
Net Cash Flow From Operating Activities, Continuing -38,968,465 -47,403,181 681,526,548 559,400,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-05 2021-11-03 2022-02-28
Comprehensive Income/Loss -41,767,842 -50,532,351 -46,941,857 -196,200,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -41,767,842 -50,532,351 -46,941,857 -196,200,000
Other Comprehensive Income/Loss -803,551 -50,532,351 -46,941,857 -5,200,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-05 2021-11-03 2022-02-28
Basic Earnings Per Share UNPUB UNPUB UNPUB -4
Benefits Costs and Expenses 46,503,656 0 0 237,700,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 46,503,656 57,421,672 56,616,015 237,700,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB -4
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -40,964,291 -50,288,562 -46,751,752 -191,000,000
Income/Loss From Continuing Operations Before Tax -40,964,291 5,544,418 9,284,785 -191,000,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 16,250 8,125 8,125 100,000
Net Income/Loss -40,964,291 -50,288,562 -46,751,752 -191,000,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -40,964,291 -50,288,562 -46,751,752 -191,000,000
Net Income/Loss Available To Common Stockholders, Basic -40,964,291 -50,288,562 -46,751,752 -191,000,000
Operating Expenses 47,185,595 57,421,672 56,616,015 242,000,000
Operating Income/Loss -41,646,230 -51,877,254 -47,331,230 -195,300,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,539,365 5,544,418 9,284,785 46,700,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-28 2020-08-04 2020-11-05 2021-03-01
Assets 282,449,799 262,581,573 271,947,431 717,368,587
Current Assets 270,195,164 249,581,888 257,979,829 703,087,626
Current Liabilities 33,168,990 33,719,801 39,530,518 49,085,420
Equity 211,707,113 197,781,424 205,119,967 642,257,512
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 211,707,113 197,781,424 205,119,967 642,257,512
Liabilities 70,742,686 64,800,149 66,827,464 75,111,075
Liabilities And Equity 282,449,799 262,581,573 271,947,431 717,368,587
Noncurrent Assets 12,254,635 12,999,685 13,967,602 14,280,961
Noncurrent Liabilities 0 0 27,296,946 26,025,655
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-28 2020-08-04 2020-11-05 2021-03-01
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 26,895,266 -14,512,667 67,395,265 579,162,175
Net Cash Flow, Continuing 26,895,266 -14,512,667 67,395,265 579,162,175
Net Cash Flow From Financing Activities 1,350,482 1,279,153 30,495,805 504,669,030
Net Cash Flow From Financing Activities, Continuing 1,350,482 1,279,153 30,495,805 504,669,030
Net Cash Flow From Investing Activities 42,494,745 5,610,166 59,283,295 164,250,079
Net Cash Flow From Investing Activities, Continuing 42,494,745 5,610,166 59,283,295 164,250,079
Net Cash Flow From Operating Activities -16,949,961 -21,401,986 -22,383,835 -89,756,934
Net Cash Flow From Operating Activities, Continuing -16,949,961 -21,401,986 -22,383,835 -89,756,934
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-28 2020-08-04 2020-11-05 2021-03-01
Comprehensive Income/Loss -22,449,361 -22,959,801 -31,404,183 -118,878,844
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -22,449,361 -22,959,801 -31,404,183 -118,878,844
Other Comprehensive Income/Loss -710,190 -22,959,801 -31,404,183 453,220
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-28 2020-08-04 2020-11-05 2021-03-01
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 27,978,799 0 0 141,133,841
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 27,978,799 32,231,564 39,344,843 141,133,841
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,739,171 -25,226,539 -30,819,866 -119,332,064
Income/Loss From Continuing Operations Before Tax -21,739,171 5,747,681 7,596,776 -119,332,064
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 16,250 16,250 16,250 65,000
Net Income/Loss -21,739,171 -25,226,539 -30,819,866 -119,332,064
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,739,171 -25,226,539 -30,819,866 -119,332,064
Net Income/Loss Available To Common Stockholders, Basic -21,739,171 -25,226,539 -30,819,866 -119,332,064
Operating Expenses 29,651,691 32,231,564 39,344,843 146,659,254
Operating Income/Loss -23,412,063 -26,483,883 -31,748,067 -124,857,477
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 6,239,628 5,747,681 7,596,776 21,801,777
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-05 2019-11-04 2020-03-16
Assets 186,568,127 172,046,128 209,093,798 301,641,426
Current Assets 179,735,878 163,261,088 199,663,343 290,880,635
Current Liabilities 20,600,172 20,945,773 29,396,265 32,813,152
Equity 127,737,692 116,505,261 134,159,598 226,686,281
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 127,737,692 116,505,261 134,159,598 226,686,281
Liabilities 58,830,434 55,540,868 74,934,200 74,955,145
Liabilities And Equity 186,568,127 172,046,128 209,093,798 301,641,426
Noncurrent Assets 6,832,249 8,785,040 9,430,455 10,760,791
Noncurrent Liabilities 0 0 45,537,935 42,141,993
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-05 2019-11-04 2020-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 25,596,191 -17,444,069 793,297 6,021,001
Net Cash Flow, Continuing 25,596,191 -17,444,069 793,297 6,021,001
Net Cash Flow From Financing Activities -45,542 353,086 30,754,335 139,743,906
Net Cash Flow From Financing Activities, Continuing -45,542 353,086 30,754,335 139,743,906
Net Cash Flow From Investing Activities 38,374,102 -4,228,072 -31,814,671 -93,096,563
Net Cash Flow From Investing Activities, Continuing 38,374,102 -4,228,072 -31,814,671 -93,096,563
Net Cash Flow From Operating Activities -12,732,369 -13,569,083 1,853,633 -40,626,342
Net Cash Flow From Operating Activities, Continuing -12,732,369 -13,569,083 1,853,633 -40,626,342
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-05 2019-11-04 2020-03-16
Comprehensive Income/Loss -14,404,492 -17,164,646 -17,675,373 -69,966,928
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -14,106,738 -16,944,527 -17,778,878 -69,966,928
Other Comprehensive Income/Loss 0 0 0 325,299
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-05 2019-11-04 2020-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 113,268,705
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 19,830,988 22,441,417 24,545,414 113,268,705
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -14,404,492 -17,164,646 -17,675,373 -70,292,227
Income/Loss From Continuing Operations Before Tax 4,016,489 4,016,489 30,050,227 -70,292,227
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating 23,638 22,778 22,903 85,569
Net Income/Loss -14,404,492 -17,164,646 -17,675,373 -70,292,227
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -14,404,492 -17,164,646 -17,675,373 -70,292,227
Net Income/Loss Available To Common Stockholders, Basic -14,404,492 -17,164,646 -17,675,373 -70,292,227
Operating Expenses 19,830,988 22,441,417 24,545,414 94,500,992
Operating Income/Loss -15,814,499 -18,424,928 5,504,813 -51,524,514
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 4,016,489 4,016,489 30,050,227 42,976,478
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2018-11-14 2019-03-26
Assets UNPUB UNPUB 98,886,058 199,281,575
Current Assets UNPUB UNPUB 95,518,056 195,677,779
Current Liabilities UNPUB UNPUB 19,847,631 22,979,878
Equity UNPUB UNPUB -278,842,379 136,666,983
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB -278,842,379 136,666,983
Liabilities UNPUB UNPUB 62,561,581 62,614,592
Liabilities And Equity UNPUB UNPUB 98,886,058 199,281,575
Noncurrent Assets UNPUB UNPUB 3,368,002 3,603,796
Noncurrent Liabilities UNPUB UNPUB 42,713,950 39,634,714
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2018-11-14 2019-03-26
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB -27,722,335
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -27,722,335
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 168,060,695
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 168,060,695
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -179,665,360
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -179,665,360
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -16,117,670
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -16,117,670
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2018-11-14 2019-03-26
Comprehensive Income/Loss UNPUB UNPUB -13,387,672 -41,688,438
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -13,338,281 -41,688,438
Other Comprehensive Income/Loss UNPUB UNPUB 0 -207,972
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2018-11-14 2019-03-26
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB 0 55,804,386
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 17,434,110 55,804,386
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB -13,387,672 -41,480,466
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB -13,387,672 -41,480,466
Income Tax Expense/Benefit UNPUB UNPUB 0 0
Interest Expense, Operating UNPUB UNPUB 12,264 57,440
Net Income/Loss UNPUB UNPUB -13,387,672 -41,480,466
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB -13,387,672 -41,480,466
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -125,438,281 -239,847,222
Operating Expenses UNPUB UNPUB 17,434,110 58,125,998
Operating Income/Loss UNPUB UNPUB -14,058,846 -43,802,078
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 112,050,609 198,366,756
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 112,050,609 198,366,756
Revenues UNPUB UNPUB 3,375,264 14,323,920
Calendar
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:ARVN240517P00065000 OPASPS Put American 100 65 BATO 2024-05-17
O:ARVN240517P00060000 OPASPS Put American 100 60 BATO 2024-05-17
O:ARVN240517P00055000 OPASPS Put American 100 55 BATO 2024-05-17
O:ARVN240517P00050000 OPASPS Put American 100 50 BATO 2024-05-17
O:ARVN240517P00045000 OPASPS Put American 100 45 BATO 2024-05-17
O:ARVN240517P00040000 OPASPS Put American 100 40 BATO 2024-05-17
O:ARVN240517P00035000 OPASPS Put American 100 35 BATO 2024-05-17
O:ARVN240517P00030000 OPASPS Put American 100 30 BATO 2024-05-17
O:ARVN240517P00025000 OPASPS Put American 100 25 BATO 2024-05-17
O:ARVN240517P00022500 OPASPS Put American 100 22.5 BATO 2024-05-17
O:ARVN240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:ARVN240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:ARVN240517C00065000 OCASPS Call American 100 65 BATO 2024-05-17
O:ARVN240517C00060000 OCASPS Call American 100 60 BATO 2024-05-17
O:ARVN240517C00055000 OCASPS Call American 100 55 BATO 2024-05-17
O:ARVN240517C00050000 OCASPS Call American 100 50 BATO 2024-05-17
O:ARVN240517C00045000 OCASPS Call American 100 45 BATO 2024-05-17
O:ARVN240517C00040000 OCASPS Call American 100 40 BATO 2024-05-17
O:ARVN240517C00035000 OCASPS Call American 100 35 BATO 2024-05-17
O:ARVN240517C00030000 OCASPS Call American 100 30 BATO 2024-05-17
O:ARVN240517C00025000 OCASPS Call American 100 25 BATO 2024-05-17
O:ARVN240517C00022500 OCASPS Call American 100 22.5 BATO 2024-05-17
O:ARVN240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:ARVN240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:ARVN240419P00070000 OPASPS Put American 100 70 BATO 2024-04-19
O:ARVN240419P00065000 OPASPS Put American 100 65 BATO 2024-04-19
O:ARVN240419C00070000 OCASPS Call American 100 70 BATO 2024-04-19
O:ARVN240419C00065000 OCASPS Call American 100 65 BATO 2024-04-19
O:ARVN240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:ARVN240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:ARVN240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:ARVN240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:ARVN240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:ARVN240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:ARVN240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:ARVN240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:ARVN240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:ARVN240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:ARVN240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:ARVN240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:ARVN240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:ARVN240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:ARVN240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:ARVN240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:ARVN240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:ARVN240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:ARVN240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:ARVN240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:ARVN240419P00060000 OPASPS Put American 100 60 BATO 2024-04-19
O:ARVN240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:ARVN240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:ARVN240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:ARVN240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:ARVN240419C00060000 OCASPS Call American 100 60 BATO 2024-04-19
O:ARVN240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:ARVN240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:ARVN240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:ARVN240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:ARVN240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:ARVN240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:ARVN240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:ARVN240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:ARVN240315C00065000 OCASPS Call American 100 65 BATO 2024-03-15
O:ARVN240315C00060000 OCASPS Call American 100 60 BATO 2024-03-15
O:ARVN240315P00055000 OPASPS Put American 100 55 BATO 2024-03-15
O:ARVN240315P00050000 OPASPS Put American 100 50 BATO 2024-03-15
O:ARVN240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:ARVN240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:ARVN240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:ARVN240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:ARVN240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:ARVN240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:ARVN240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:ARVN240315C00055000 OCASPS Call American 100 55 BATO 2024-03-15
O:ARVN240315C00050000 OCASPS Call American 100 50 BATO 2024-03-15
O:ARVN240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:ARVN240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:ARVN240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:ARVN240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:ARVN240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:ARVN240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:ARVN240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:ARVN240315P00065000 OPASPS Put American 100 65 BATO 2024-03-15
O:ARVN240315P00060000 OPASPS Put American 100 60 BATO 2024-03-15
O:ARVN240216P00060000 OPASPS Put American 100 60 BATO 2024-02-16
O:ARVN240216C00060000 OCASPS Call American 100 60 BATO 2024-02-16
O:ARVN240216P00055000 OPASPS Put American 100 55 BATO 2024-02-16
O:ARVN240216P00050000 OPASPS Put American 100 50 BATO 2024-02-16
O:ARVN240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:ARVN240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:ARVN240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:ARVN240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:ARVN240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:ARVN240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:ARVN240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:ARVN240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:ARVN240216C00055000 OCASPS Call American 100 55 BATO 2024-02-16
O:ARVN240216C00050000 OCASPS Call American 100 50 BATO 2024-02-16
O:ARVN240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:ARVN240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:ARVN240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:ARVN240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:ARVN240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:ARVN240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:ARVN240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:ARVN240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:ARVN240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:ARVN240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:ARVN240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:ARVN240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:ARVN240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:ARVN240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:ARVN240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:ARVN240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:ARVN240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:ARVN240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:ARVN240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:ARVN240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:ARVN240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:ARVN240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:ARVN240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:ARVN240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:ARVN240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:ARVN240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:ARVN240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:ARVN240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:ARVN240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:ARVN240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:ARVN240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:ARVN240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:ARVN240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:ARVN240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:ARVN240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:ARVN240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:ARVN240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:ARVN240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:ARVN240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:ARVN240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:ARVN231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:ARVN231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:ARVN231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:ARVN231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:ARVN231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:ARVN231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:ARVN231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:ARVN231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:ARVN231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:ARVN231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:ARVN231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:ARVN231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:ARVN231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:ARVN231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:ARVN231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:ARVN231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:ARVN231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:ARVN231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:ARVN231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:ARVN231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:ARVN231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:ARVN231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:ARVN231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:ARVN231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:ARVN231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:ARVN231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:ARVN231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:ARVN231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:ARVN231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:ARVN231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:ARVN231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:ARVN231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:ARVN231117P00022500 OPASPS Put American 100 22.5 BATO 2023-11-17
O:ARVN231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:ARVN231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:ARVN231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:ARVN231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:ARVN231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:ARVN231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:ARVN231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:ARVN231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:ARVN231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:ARVN231117C00022500 OCASPS Call American 100 22.5 BATO 2023-11-17
O:ARVN231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:ARVN231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:ARVN231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:ARVN231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:ARVN231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:ARVN231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:ARVN231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:ARVN231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:ARVN231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:ARVN231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:ARVN231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:ARVN231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:ARVN231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:ARVN231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:ARVN231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:ARVN231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:ARVN231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:ARVN231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:ARVN231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:ARVN231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:ARVN231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:ARVN231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:ARVN231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:ARVN231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:ARVN231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:ARVN231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:ARVN231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:ARVN231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:ARVN231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:ARVN230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:ARVN230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:ARVN230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:ARVN230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:ARVN230915P00020000 OPASPS Put American 100 20 BATO 2023-09-15
O:ARVN230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:ARVN230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:ARVN230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:ARVN230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:ARVN230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:ARVN230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:ARVN230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:ARVN230915C00020000 OCASPS Call American 100 20 BATO 2023-09-15
O:ARVN230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:ARVN230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:ARVN230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:ARVN230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:ARVN230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:ARVN230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:ARVN230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:ARVN230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:ARVN230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:ARVN230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:ARVN230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:ARVN230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:ARVN230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:ARVN230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:ARVN230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:ARVN230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:ARVN230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:ARVN230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
O:ARVN230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:ARVN230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:ARVN230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
News Stream
News Clinical Study
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in combination with palbociclib were consistent with data previously reported at SABCS in December 2023 –
GlobeNewswire Inc. • 3d ago
Calendar Calendar of Events
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
NEW HAVEN, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that two posters, including updated clinical trial data, for vepdegestrant will be presented at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress held from May 15-17, 2024, in Berlin, Germany. Vepdegestrant is a novel investigational PROTAC® estrogen receptor (ER) degrader that is being jointly developed by Arvinas and Pfizer for the treatment of patients with early and locally advanced or metastatic ER positive/human epidermal growth factor receptor 2 (HER2) negative (ER+/HER2-) breast cancer.
GlobeNewswire Inc. • 1w ago
Stocks Earnings Releases and Operating Results
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
– Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast cancer, including the VERITAC-2 Phase 3 trial in the second-line setting and the study lead-in for the VERITAC-3 Phase 3 trial in the first-line setting –
GlobeNewswire Inc. • 1w ago
Management Directors and Officers
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer. Dr. Teel currently serves as Arvinas’ interim Chief Financial Officer and Treasurer, and in his new role, he will remain a member of the Executive Committee reporting to Chairperson, President and Chief Executive Officer, John Houston, Ph.D. Dr. Teel will remain in these interim roles at Arvinas while the board of directors continues its search for a permanent Chief Financial Officer and Treasurer.
GlobeNewswire Inc. • 3w ago
Stocks Licensing Agreements
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
– Arvinas to receive a $150 million upfront payment for the license of ARV-766 and the sale of Arvinas’ preclinical AR-V7 program, with the potential under the License Agreement for up to $1.01 billion in development, regulatory, and commercial milestones, as well as tiered royalties –
GlobeNewswire Inc. • 1mo ago
News News
Is Arvinas (ARVN) Stock a Solid Choice Right Now?
Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks Investment Research • 1mo ago
Management Directors and Officers
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
- Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - - Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) -
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in three upcoming investor conferences:
GlobeNewswire Inc. • 2mo ago
News News
Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?
Arvinas (ARVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks Investment Research • 2mo ago
Analyst Analyst Ratings
Navigating 7 Analyst Ratings For Arvinas
Arvinas (NASDAQ:ARVN) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 2 0 0 Last 30D 0 2 0 0 0 1M Ago 1 0 2 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Arvinas, presenting an average target of $60.29, a high estimate of $80.00, and a low estimate of $40.00. Witnessing a positive shift, the current average has risen by 29.94% from the previous average price target of $46.40. Deciphering Analyst Ratings: An In-Depth Analysis A comprehensive examination of how financial experts perceive Arvinas is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Robert Driscoll Wedbush Raises Outperform $59.00 $33.00 Matthew Biegler Oppenheimer Lowers Outperform $80.00 $95.00 Yigal Nochomovitz Citigroup Raises Neutral $55.00 $36.00 Yigal Nochomovitz Citigroup Raises Neutral $55.00 $36.00 Paul Choi Goldman Sachs Announces Buy $70.00 - Derek Archila Wells Fargo Announces Overweight $63.00 - Akash Tewari Jefferies Raises Buy $40.00 $32.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction ...Full story available on Benzinga.com
Benzinga • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT